From cue to meaning: The involvement of POLD1 gene in DNA replication, repair and aging.


Journal

Mechanisms of ageing and development
ISSN: 1872-6216
Titre abrégé: Mech Ageing Dev
Pays: Ireland
ID NLM: 0347227

Informations de publication

Date de publication:
04 2023
Historique:
received: 01 12 2022
revised: 06 02 2023
accepted: 06 02 2023
medline: 11 4 2023
pubmed: 11 2 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

Aging is an extremely complex biological process. Aging, cancer and inflammation represent a trinity, object of many interesting researches. The accumulation of DNA damage and its consequences progressively interfere with cellular function and increase susceptibility to developing aging condition. DNA Polymerase delta (Pol δ), encoded by POLD1 gene (MIM#174761) on 19q13.3, is well implicated in many steps of the replication program and repair. Thanks to its exonuclease and polymerase activities, the enzyme is involved in the regulation of the cell cycle, DNA synthesis, and DNA damage repair processes. Damaging variants within the exonuclease domain predispose to cancers, while those occurring in the polymerase active site cause the autosomal dominant Progeroid Syndrome called MDPL, Mandibular hypoplasia, Deafness and Progeroid features with concomitant Lipodystrophy Since DNA damage represents the main cause of ageing and age-related pathologies, an overview of critical Pol δ activities will allow to better understand the associations between DNA damage and nearly every aspect of the ageing process, helping the researchers to counteract all the ageing-pathologies at the same time.

Identifiants

pubmed: 36764464
pii: S0047-6374(23)00016-7
doi: 10.1016/j.mad.2023.111790
pii:
doi:

Substances chimiques

DNA Polymerase III EC 2.7.7.7
Exonucleases EC 3.1.-
POLD1 protein, human EC 2.7.7.-

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111790

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Auteurs

Michela Murdocca (M)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. Electronic address: miky.murdi@hotmail.it.

Paola Spitalieri (P)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. Electronic address: paola.spitalieri@uniroma2.it.

Maria Rosaria D'Apice (MR)

Laboratory of Medical Genetics, Tor Vergata Hospital, Rome, Italy. Electronic address: d.apice@med.uniroma2.it.

Giuseppe Novelli (G)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy; University of Nevada, Department of Pharmacology, Reno, USA; Neuromed Institute, IRCCS, Pozzilli, IS, Italy. Electronic address: novelli@med.uniroma2.it.

Federica Sangiuolo (F)

Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. Electronic address: sangiuolo@med.uniroma2.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH